Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Influenza

Free Subscription Articles published in Virus Res Retrieve available abstracts of 117 articles: HTML format

Single Articles

June 2026
1. TJARNHAGE E, Vatsveen TK, Raki M, Nemazee D, et al
   Repurposing ALK Inhibitors as Influenza and Corona Virus Antivirals Targeting Lymphocyte Tyrosine Kinase (LTK).
   Virus Res. 2026 Jun 9:199759. doi: 10.1016/j.virusres.2026.199759.
   PubMed     Abstract available
   
   
   
2. JANGJOU A, Izadpanah P, Moqhadas M, Faramarzi H, et al
   QT interval prolongation and its related factors before and after receiving lopinavir-ritonavir in the COVID-19 era: a historical cohort study.
   Virus Res. 2026;368:199739.
   PubMed     Abstract available
   
   
   
3. VAN DIJK LLA, Rijsbergen LC, Havelaar AC, den Hartog Y, et al
   Innate airway responses shape permissiveness to human respiratory syncytial virus.
   Virus Res. 2026;368:199734.
   PubMed     Abstract available
   
   
   May 2026
4. SEDAGHAT M, Najafi F, Khosravi Shademani F, Rezaeian S, et al
   Seasonal influenza vaccine and frequency of adverse events in health workers receiving two doses of AstraZeneca vaccine: a retrospective cohort study.
   Virus Res. 2026;369:199757.
   PubMed     Abstract available
   
   
   
5. LIU Y, Wang C, Yan D, Zhang Y, et al
   Prognostic prediction in COVID-19 patients: a comprehensive analysis of gut microbiota and hematological biomarkers.
   Virus Res. 2026;367:199729.
   PubMed     Abstract available
   
   
   
6. NAGHIBOSADAT M, Hahn E, Molinaro S, Babuadze G, et al
   Comparison of SARS-CoV-2 variant pathogenicity in a long-COVID Syrian hamster model.
   Virus Res. 2026;367:199711.
   PubMed     Abstract available
   
   
   
7. WANG X, Guo J, Liu J, Jiang J, et al
   Shared genetic structure between COVID-19 and migraine: insights from large-scale genome-wide cross-trait analysis.
   Virus Res. 2026;367:199708.
   PubMed     Abstract available
   
   
   April 2026
8. FARSIU N, Mahani FK, Arefinia N, Charostad J, et al
   From Legacy to Innovation: A Comprehensive Review of Vaccine Platforms Against Viral Infections.
   Virus Res. 2026 Apr 16:199730. doi: 10.1016/j.virusres.2026.199730.
   PubMed     Abstract available
   
   
   
9. WU Y, Sun W, Xia Y, Feng Y, et al
   The influenza B virus candidate vaccine expressing H3 hemagglutinin developed in suspension MDCK cells confers protection against lethal H3N2 avian influenza in BALB/c mice.
   Virus Res. 2026;367:199722.
   PubMed     Abstract available
   
   
   
10. XIE C, Zhao Y, Wang B, He T, et al
    Identification of key genes modules linking brain aging signatures and COVID-19-associated cognitive impairment.
    Virus Res. 2026;366:199707.
    PubMed     Abstract available
    
    
    
11. SITHOLE MN, Khan MR, Mohammed HA, Khan RA, et al
    A Systematic Review on Vaccine Developmental Approaches: Evaluating Efficacy, and Addressing Challenges of Infectious Diseases in the Post-COVID-19 Era.
    Virus Res. 2026 Apr 1:199720. doi: 10.1016/j.virusres.2026.199720.
    PubMed     Abstract available
    
    
    March 2026
12. FERREIRO I, Hurtado J, Bruno A, Cristina J, et al
    On the brink of emergence: an evolutionary approach to Influenza A virus H5N1 isolated from humans.
    Virus Res. 2026 Mar 21:199717. doi: 10.1016/j.virusres.2026.199717.
    PubMed     Abstract available
    
    
    February 2026
13. LUO X, Liu H, Kuang H, Xie Y, et al
    Impacts of Delayed Influenza Vaccination on Clinical Outcomes in ICU-Admitted Patients with Influenza: A Retrospective Cohort Study.
    Virus Res. 2026 Feb 3:199700. doi: 10.1016/j.virusres.2026.199700.
    PubMed     Abstract available
    
    
    January 2026
14. NAZKI S, Reine J, Kailath R, Gilbert S, et al
    Replication-incompetent viral vaccine vectors ChAdOx1 and MVA as tools for evaluating T-cell responses to naturally processed antigens in vitro.
    Virus Res. 2026;364:199691.
    PubMed     Abstract available
    
    
    
15. CAI H, Hou L, Chang J, Yang Q, et al
    Venenum bufonis and its active constituents alleviate RSV-induced pneumonia in mice by suppressing macrophage infiltration and NLRP3 inflammasome activation.
    Virus Res. 2026;363:199672.
    PubMed     Abstract available
    
    
    December 2025
16. LUO L, Lv J
    Stochastic mutation as a mechanism for the emergence of SARS-CoV-2 new variants.
    Virus Res. 2025;362:199667.
    PubMed     Abstract available
    
    
    November 2025
17. GABBAY U, Carmi D
    The Paradox of Rapid and Synchronized Propagation of Seasonal Influenza 'A' Outbreaks in Contrast with COVID-19: a Testable Hypothesis.
    Virus Res. 2025 Nov 26:199670. doi: 10.1016/j.virusres.2025.199670.
    PubMed     Abstract available
    
    
    
18. LI X, Xiao M
    Retrospective study on the correlation between biochemical and blood routine indexes and prognosis in elderly patients with influenza A (H1N1).
    Virus Res. 2025;362:199668.
    PubMed     Abstract available
    
    
    
19. HU J, Liu M, Qin B, Shen B, et al
    D-dimer drives immune dysregulation in COVID-19 via chemokine modulation and inflammatory signaling.
    Virus Res. 2025;361:199641.
    PubMed     Abstract available
    
    
    October 2025
20. RAMASAMY S, Bustamante F, LaBella LC, Cole SD, et al
    Spillover of SARS-CoV-2 to domestic dogs in COVID-19-positive households: A one health surveillance study.
    Virus Res. 2025;360:199629.
    PubMed     Abstract available
    
    
    
21. GONG T, Zhang X, Lin H, Li J, et al
    Mutation profiling, evolution analysis, molecular dynamics simulation, and functional characterization of Omicron sub-strains.
    Virus Res. 2025;360:199626.
    PubMed     Abstract available
    
    
    
22. SHI X, Wang J, Li C, Du S, et al
    Single amino acid substitution at position 614 in SARS-CoV-2 Spike Protein alters viral assembly and infectivity.
    Virus Res. 2025;360:199624.
    PubMed     Abstract available
    
    
    September 2025
23. CHAVOIX C, Massin P, Briand FX, Louboutin K, et al
    Identification of H1N2 influenza viruses in turkeys after spillover from swine and in vitro characterization.
    Virus Res. 2025 Sep 21:199634. doi: 10.1016/j.virusres.2025.199634.
    PubMed     Abstract available
    
    
    
24. VOKO Z, Turi G, Oroszi B, Belicza E, et al
    Association between COVID-19 vaccination and progression to severe outcomes in hospitalized COVID-19 patients in Hungary during the pre-Omicron era of the COVID-19 pandemic.
    Virus Res. 2025;361:199633.
    PubMed     Abstract available
    
    
    
25. WU J, Qian X, Bai S, Wu L, et al
    Lesser-known non-apoptotic programmed cell death in viral infections.
    Virus Res. 2025;359:199612.
    PubMed     Abstract available
    
    
    August 2025
26. SANZ-MUNOZ I, Martin-Toribio A, Garcia-Concejo A, Arroyo-Hernantes I, et al
    A 15-year study of neuraminidase mutations and the increasing of S247N mutation in Spain.
    Virus Res. 2025;358:199599.
    PubMed     Abstract available
    
    
    July 2025
27. CHEN Z, Cai M, Chai L, Li X, et al
    Anti-influenza Activity of Blumea Balsamifera (L.) DC. Extract: In Vitro and In Vivo Evaluation Against Multiple Influenza Virus Strains.
    Virus Res. 2025 Jul 20:199606. doi: 10.1016/j.virusres.2025.199606.
    PubMed     Abstract available
    
    
    
28. MARTINEZ ES, Fuchs S, Szurmant H, Chen X, et al
    COVID-19 mRNA vaccine immune response to the addition of osteopathic manipulative treatment with lymphatic pumps: a randomized controlled trial.
    Virus Res. 2025 Jul 14:199607. doi: 10.1016/j.virusres.2025.199607.
    PubMed     Abstract available
    
    
    
29. SHEN CH, Tsai HP, Chou CC, Yeh CS, et al
    Plant MIR2911 in honeysuckle is effective against SARS-CoV-2 variant.
    Virus Res. 2025;357:199583.
    PubMed     Abstract available
    
    
    June 2025
30. MATSUZAKI Y, Sugawara K, Kadowaki Y, Kidoguchi Y, et al
    Characterization of Antigenically Dominant Regions in the Hemagglutinin Protein of B/Victoria-Lineage Influenza B Virus Using Monoclonal Antibody Escape Mutants.
    Virus Res. 2025 Jun 14:199598. doi: 10.1016/j.virusres.2025.199598.
    PubMed     Abstract available
    
    
    
31. ZHOU X, Feng L
    The Association Between Influenza Infection and Acute Myocardial Infarction: A Comprehensive Systematic Review and Meta-Analysis.
    Virus Res. 2025 Jun 9:199594. doi: 10.1016/j.virusres.2025.199594.
    PubMed     Abstract available
    
    
    
32. CHEN J, Zhao S, Yan H, Huang Y, et al
    Plasma SARS-CoV-2 nucleocapsid antigen levels are associated with lung infection and tissue-damage biomarkers.
    Virus Res. 2025;356:199580.
    PubMed     Abstract available
    
    
    May 2025
33. YANG W, Tao T, Zhang J, Yao Y, et al
    The association of cycle threshold value with clinical features in patients infected with Omicron variant.
    Virus Res. 2025;355:199565.
    PubMed     Abstract available
    
    
    
34. YAN J, Liu F, Hu S, Pan J, et al
    Regional dynamics and mechanisms behind SARS-CoV-2 XDV.1 prevalence in Chongqing via genomic surveillance and molecular insights.
    Virus Res. 2025;355:199562.
    PubMed     Abstract available
    
    
    
35. ZADEH VR, Lew JM, Zahoor MA, Santer D, et al
    Combination therapy enhances the antiviral activity of IFN-lambda against SARS-CoV-2 and MERS-CoV.
    Virus Res. 2025;355:199560.
    PubMed     Abstract available
    
    
    
36. ZHAO X, Zhu X, Wang J, Ye C, et al
    The epidemiological analysis of respiratory virus infections in Children in Hangzhou from 2019 to 2023.
    Virus Res. 2025;355:199558.
    PubMed     Abstract available
    
    
    April 2025
37. CHEN N, Jin J, Qiao B, Gao Z, et al
    JNK kinase promotes inflammatory responses by inducing the expression of the inflammatory amplifier TREM1 during influenza a virus infection.
    Virus Res. 2025;356:199577.
    PubMed     Abstract available
    
    
    March 2025
38. MYERS ML, Conlon MT, Gallagher JR, Woolfork DD, et al
    Analysis of polyclonal and monoclonal antibody to the influenza virus nucleoprotein in different oligomeric states.
    Virus Res. 2025 Mar 24:199563. doi: 10.1016/j.virusres.2025.199563.
    PubMed     Abstract available
    
    
    
39. GHAMMAZ H, Melloul M, Mbarki A, Hemlali M, et al
    Genomic evolution of SARS-CoV-2 in Morocco: Insights from whole genome sequences collected from 2020 to 2024.
    Virus Res. 2025;353:199530.
    PubMed     Abstract available
    
    
    January 2025
40. CHA RM, Park MJ, Baek YG, Lee YN, et al
    Genetic characteristics and pathogenesis of clade 2.3.4.4b H5N1 high pathogenicity avian influenza virus isolated from poultry in South Korea, 2022-2023.
    Virus Res. 2025 Jan 31:199541. doi: 10.1016/j.virusres.2025.199541.
    PubMed     Abstract available
    
    
    
41. EL HOUDI M, Skhoun H, El Fessikh M, Benmansour R, et al
    Association study of the JAK/STAT signaling pathway with susceptibility to COVID-19 in moroccan patient and in-silico analysis of rare variants.
    Virus Res. 2025;351:199509.
    PubMed     Abstract available
    
    
    
42. DEZORDI FZ, Junior JVJS, Ruoso TF, Batista AG, et al
    Higher frequency of interstate over international transmission chains of SARS-CoV-2 virus at the Rio Grande do Sul - Brazil state borders.
    Virus Res. 2025;351:199500.
    PubMed     Abstract available
    
    
    December 2024
43. KOMAMI M, Komu JG, Ishiguro Y, Sasaki M, et al
    Detection of antibodies against H5 subtype highly pathogenic avian influenza viruses in multiple raccoons in Tokachi District, Hokkaido, Japan, from 2022 to 2023.
    Virus Res. 2024 Dec 15:199515. doi: 10.1016/j.virusres.2024.199515.
    PubMed     Abstract available
    
    
    
44. MAO B, Le-Trilling VTK, Tang H, Hu J, et al
    Diphyllin elicits a doubled-pronged attack on the entry of SARS-CoV-2 by inhibiting cathepsin L and furin.
    Virus Res. 2024;350:199485.
    PubMed     Abstract available
    
    
    
45. GIRMA A
    Biology of human respiratory syncytial virus: Current perspectives in immune response and mechanisms against the virus.
    Virus Res. 2024;350:199483.
    PubMed     Abstract available
    
    
    
46. KUROSE M, Yamamoto A, Elsayed AMA, Lawal-Ayinde BM, et al
    Viral coexistence and insertional mutations in the ORF8 region of SARS-CoV-2: A possible mechanism of nucleotide insertion.
    Virus Res. 2024;350:199478.
    PubMed     Abstract available
    
    
    
47. NO JS, Noh JY, Lee CY, Kim IH, et al
    Dynamics of SARS-CoV-2 variants during the XBB wave in the Republic of Korea.
    Virus Res. 2024;350:199471.
    PubMed     Abstract available
    
    
    November 2024
48. DELL'ANNUNZIATA F, Mosidze E, Folliero V, Lamparelli EP, et al
    Eco-friendly synthesis of silver nanoparticles from peel and juice C. limon and their antiviral efficacy against HSV-1 and SARS-CoV-2.
    Virus Res. 2024;349:199455.
    PubMed     Abstract available
    
    
    October 2024
49. ELHUSSEINY MH, Elsayed MM, Mady WH, Mahana O, et al
    Genetic features of avian influenza (A/H5N8) clade 2.3.4.4b isolated from quail in Egypt.
    Virus Res. 2024;350:199482.
    PubMed     Abstract available
    
    
    
50. PAZ M, Franco-Trecu V, Szteren D, Costabile A, et al
    Understanding the emergence of highly pathogenic avian Influenza A virus H5N1 in pinnipeds: an evolutionary approach.
    Virus Res. 2024 Oct 1:199472. doi: 10.1016/j.virusres.2024.199472.
    PubMed     Abstract available
    
    
    September 2024
51. KO EA, Zhou T, Ko JH
    Insight into noncanonical small noncoding RNAs in Influenza A virus infection.
    Virus Res. 2024;350:199474.
    PubMed     Abstract available
    
    
    
52. SONDLANE H, Ogunbayo A, Donato C, Mogotsi M, et al
    Whole genome molecular analysis of respiratory syncytial virus pre and during the COVID-19 pandemic in Free State province, South Africa.
    Virus Res. 2024;347:199421.
    PubMed     Abstract available
    
    
    August 2024
53. LEIST SR, Schafer A, Risemberg EL, Bell TA, et al
    Sarbecovirus disease susceptibility is conserved across viral and host models.
    Virus Res. 2024;346:199399.
    PubMed     Abstract available
    
    
    July 2024
54. WANG Y, Yu H, Zhang T, Sun Z, et al
    Associations between genetic mutations in different SARS-CoV-2 strains and negative conversion time of viral RNA among imported cases in Hangzhou: A cross-sectional study.
    Virus Res. 2024;345:199400.
    PubMed     Abstract available
    
    
    
55. CHIEN Y, Huang XY, Yarmishyn AA, Chien CS, et al
    Paracrinal regulation of neutrophil functions by coronaviral infection in iPSC-derived alveolar type II epithelial cells.
    Virus Res. 2024;345:199391.
    PubMed     Abstract available
    
    
    
56. CHIRUMBOLO S, Franzini M, Tirelli U
    Does PI-ME/CFS recall post-COVID (PASC) syndrome?
    Virus Res. 2024;345:199393.
    PubMed    
    
    
    
57. BAI H, Zhang X, Gong T, Ma J, et al
    A systematic mutation analysis of 13 major SARS-CoV-2 variants.
    Virus Res. 2024;345:199392.
    PubMed     Abstract available
    
    
    June 2024
58. TAKADATE Y, Mine J, Tsunekuni R, Sakuma S, et al
    Genetic diversity of H5N1 and H5N2 high pathogenicity avian influenza viruses isolated from poultry in Japan during the winter of 2022-2023.
    Virus Res. 2024;347:199425.
    PubMed     Abstract available
    
    
    
59. RIVETTI AV JR, Reischak D, de Oliveira CHS, Otaka JNP, et al
    Phylodynamics of avian influenza A(H5N1) viruses from outbreaks in Brazil.
    Virus Res. 2024;347:199415.
    PubMed     Abstract available
    
    
    
60. KHAIRNAR K, Tomar SS
    COVID-19 genome surveillance: A geographical landscape and mutational mapping of SARS-CoV-2 variants in central India over two years.
    Virus Res. 2024;344:199365.
    PubMed     Abstract available
    
    
    
61. LUO L, Lv J
    An evolutionary theory on virus mutation in COVID-19.
    Virus Res. 2024;344:199358.
    PubMed     Abstract available
    
    
    
62. SCHAFER A, Gralinski LE, Leist SR, Hampton BK, et al
    Genetic loci regulate Sarbecovirus pathogenesis: A comparison across mice and humans.
    Virus Res. 2024;344:199357.
    PubMed     Abstract available
    
    
    
63. SCHMITZ T, Freuer D, Gosslau Y, Warm TD, et al
    Can inflammatory plasma proteins predict Long COVID or Fatigue severity after SARS-CoV-2 infection?
    Virus Res. 2024;344:199363.
    PubMed     Abstract available
    
    
    
64. KHEMIRI H, Mangone I, Gdoura M, Mefteh K, et al
    Dynamic of SARS-CoV-2 variants circulation in Tunisian pediatric population, during successive waves, from March 2020 to September 2022.
    Virus Res. 2024;344:199353.
    PubMed     Abstract available
    
    
    May 2024
65. XU C, Wang Z, Yu B, Pan Z, et al
    Simultaneous and ultrafast detection of pan-SARS-coronaviruses and influenza A/B viruses by a novel multiplex real-time RT-PCR assay.
    Virus Res. 2024 May 28:199410. doi: 10.1016/j.virusres.2024.199410.
    PubMed     Abstract available
    
    
    
66. LIN X, Yang F, Yan S, Wu H, et al
    Preparation and characterization of mouse-derived monoclonal antibodies against the hemagglutinin of the H1N1 influenza virus.
    Virus Res. 2024;345:199402.
    PubMed     Abstract available
    
    
    
67. WU CC, Tam EH, Shih YY, Lin YR, et al
    Exploration of influenza A virus PA protein-associated cellular proteins discloses its impact on mitochondrial function.
    Virus Res. 2024 May 6:199387. doi: 10.1016/j.virusres.2024.199387.
    PubMed     Abstract available
    
    
    
68. GLENET M, Lebreil AL, N'Guyen Y, Meyer I, et al
    Structural impact of a new spike Y170W mutation detected in early emerging SARS-CoV-2 Omicron variants in France.
    Virus Res. 2024;343:199354.
    PubMed     Abstract available
    
    
    
69. KUZIKOV M, Reinshagen J, Wycisk K, Corona A, et al
    Drug repurposing screen to identify inhibitors of the RNA polymerase (nsp12) and helicase (nsp13) from SARS-CoV-2 replication and transcription complex.
    Virus Res. 2024;343:199356.
    PubMed     Abstract available
    
    
    April 2024
70. WANG Z, Sun W, Li D, Sun Y, et al
    A live attenuated influenza B virus vaccine expressing RBD elicits protective immunity against SARS-CoV-2 in mice.
    Virus Res. 2024;345:199378.
    PubMed     Abstract available
    
    
    
71. PAYEN SH, Adhikari K, Petereit J, Uppal T, et al
    SARS-CoV-2 superinfection in CD14(+) monocytes with latent human cytomegalovirus (HCMV) promotes inflammatory cascade.
    Virus Res. 2024;345:199375.
    PubMed     Abstract available
    
    
    
72. LIU D, Leung KY, Lam HY, Zhang R, et al
    Interaction and antiviral treatment of coinfection between SARS-CoV-2 and influenza in vitro.
    Virus Res. 2024;345:199371.
    PubMed     Abstract available
    
    
    
73. ZHANG S, Wang P, Shi L, Wang C, et al
    Exploring COVID-19 causal genes through disease-specific Cis-eQTLs.
    Virus Res. 2024;342:199341.
    PubMed     Abstract available
    
    
    
74. MONTENEGRO AFL, Clementino MAF, Yaochite JNU
    Type I interferon pathway genetic variants in severe COVID-19.
    Virus Res. 2024;342:199339.
    PubMed     Abstract available
    
    
    
75. LIM T, Rajoriya S, Kim B, Natasha A, et al
    In vitro broad-spectrum antiviral activity of MIT-001, a mitochondria-targeted reactive oxygen species scavenger, against severe acute respiratory syndrome coronavirus 2 and multiple zoonotic viruses.
    Virus Res. 2024;342:199325.
    PubMed     Abstract available
    
    
    March 2024
76. JANSEN JM, Meineke R, Molle A, van de Sandt CE, et al
    Selective pressure mediated by influenza virus M1(58-66) epitope-specific CD8(+)T cells promotes accumulation of extra-epitopic amino acid substitutions associated with viral resistance to these T cells.
    Virus Res. 2024;343:199355.
    PubMed     Abstract available
    
    
    
77. LARBI I, Marwa A, Souai O, Tougorti H, et al
    Phylogeographic Dynamics of H9N2 Avian Influenza Viruses in Tunisia.
    Virus Res. 2024 Mar 9:199348. doi: 10.1016/j.virusres.2024.199348.
    PubMed     Abstract available
    
    
    
78. WANG X, Cheng J, Shen L, Chen M, et al
    Rab5c promotes RSV and ADV replication by autophagy in respiratory epithelial cells.
    Virus Res. 2024;341:199324.
    PubMed     Abstract available
    
    
    
79. HUANG X, Kantonen J, Nowlan K, Nguyen NA, et al
    Mucosal-Associated Invariant T Cells are not susceptible in vitro to SARS-CoV-2 infection but accumulate into the lungs of COVID-19 patients.
    Virus Res. 2024;341:199315.
    PubMed     Abstract available
    
    
    February 2024
80. LI ZA, Bajpai AK, Wang R, Liu Y, et al
    Systems Genetics of Influenza A Virus-infected Mice Identifies TRIM21 as a Critical Regulator of Pulmonary Innate Immune Response.
    Virus Res. 2024 Feb 6:199335. doi: 10.1016/j.virusres.2024.199335.
    PubMed     Abstract available
    
    
    
81. CEBALLOS-GARZON A, Comtet-Marre S, Peyret P
    Applying targeted gene hybridization capture to viruses with a focus to SARS-CoV-2.
    Virus Res. 2024;340:199293.
    PubMed     Abstract available
    
    
    
82. ZHANG DQ, Ma QH, Yang MC, Belyakova YY, et al
    Peroxide derivatives as SARS-CoV-2 entry inhibitors.
    Virus Res. 2024;340:199295.
    PubMed     Abstract available
    
    
    
83. DE ALMEIDA MARQUES DP, Andrade LAF, Reis EVS, Clarindo FA, et al
    New anti-SARS-CoV-2 aminoadamantane compounds as antiviral candidates for the treatment of COVID-19.
    Virus Res. 2024;340:199291.
    PubMed     Abstract available
    
    
    January 2024
84. KODSI IA, Rayes DE, Koweyes J, Khoury CA, et al
    Tracking SARS-CoV-2 variants during the 2023 flu season and beyond in Lebanon.
    Virus Res. 2024;339:199289.
    PubMed     Abstract available
    
    
    
85. CHRIST W, Klingstrom J, Tynell J
    SARS-CoV-2 variant-specific differences in inhibiting the effects of the PKR-activated integrated stress response.
    Virus Res. 2024;339:199271.
    PubMed     Abstract available
    
    
    
86. CAI Z, Bai H, Ren D, Xue B, et al
    Integrin alphavbeta1 facilitates ACE2-mediated entry of SARS-CoV-2.
    Virus Res. 2024;339:199251.
    PubMed     Abstract available
    
    
    
87. ESSAIDI-LAZIOSI M, Perez-Rodriguez FJ, Alvarez C, Sattonnet-Roche P, et al
    Distinct phenotype of SARS-CoV-2 Omicron BA.1 in human primary cells but no increased host range in cell lines of putative mammalian reservoir species.
    Virus Res. 2024;339:199255.
    PubMed     Abstract available
    
    
    December 2023
88. KRISTENSEN C, Larsen LE, Trebbien R, Jensen HE, et al
    The avian influenza A virus receptor SA-alpha2,3-Gal is expressed in the porcine nasal mucosa sustaining the pig as a mixing vessel for new influenza viruses.
    Virus Res. 2023 Dec 22:199304. doi: 10.1016/j.virusres.2023.199304.
    PubMed     Abstract available
    
    
    
89. OTA K, Sakai H, Sasaki D, Mitsumoto-Kaseida F, et al
    Rapid increase in salivary IgA and broad recognition of spike protein following SARS-CoV-2 vaccination.
    Virus Res. 2023 Dec 4:199294. doi: 10.1016/j.virusres.2023.199294.
    PubMed     Abstract available
    
    
    November 2023
90. LI X, Ye Z, Plant EP
    5' copyback defective viral genomes are major component in clinical and non-clinical influenza samples.
    Virus Res. 2023;339:199274.
    PubMed     Abstract available
    
    
    October 2023
91. NEDAEI F, Esmaeili Rastaghi AR, Goodarzi E, Haji Mullah Asadullah H, et al
    Introduction and effect of natural selection analysis at common mutations of SARS-CoV-2 spike gene in Iran.
    Virus Res. 2023;336:199202.
    PubMed     Abstract available
    
    
    
92. RAHNI Z, Hosseini SM, Shahrokh S, Saeedi Niasar M, et al
    Long non-coding RNAs ANRIL, THRIL, and NEAT1 as potential circulating biomarkers of SARS-CoV-2 infection and disease severity.
    Virus Res. 2023;336:199214.
    PubMed     Abstract available
    
    
    
93. SCHINDEWOLF C, Menachery VD
    Coronavirus 2'-O-methyltransferase: A promising therapeutic target.
    Virus Res. 2023;336:199211.
    PubMed     Abstract available
    
    
    
94. BONIARDI I, Corona A, Basquin J, Basquin C, et al
    Suramin inhibits SARS-CoV-2 nucleocapsid phosphoprotein genome packaging function.
    Virus Res. 2023;336:199221.
    PubMed     Abstract available
    
    
    
95. CAO J, Gu H, Zhang X, Yun H, et al
    Intranasal inoculation of female BALB/c mice with replication-deficient human adenovirus type 5 expressing SARS-CoV-2 nucleocapsid protein aggravates lung pathology upon re-encountering the antigen.
    Virus Res. 2023;335:199201.
    PubMed     Abstract available
    
    
    September 2023
96. TAKAZAWA S, Kotaki T, Nakamura S, Utsubo C, et al
    Construction of Fosmid-based SARS-CoV-2 replicons for antiviral drug screening and replication analyses in biosafety level 2 facilities.
    Virus Res. 2023;334:199176.
    PubMed     Abstract available
    
    
    
97. STINCARELLI MA, Quagliata M, Di Santo A, Pacini L, et al
    SARS-CoV-2 inhibitory activity of a short peptide derived from internal fusion peptide of S2 subunit of spike glycoprotein.
    Virus Res. 2023;334:199170.
    PubMed     Abstract available
    
    
    
98. ANDRADE-MOLINA DA, Morey-Leon GA, Munoz-Mawyin KE, Cruz-Fatuly FF, et al
    First sequenced cases of Omicron BA.2 sublineage in Ecuador.
    Virus Res. 2023;334:199169.
    PubMed     Abstract available
    
    
    
99. WANG Z, Pan Q, Ma L, Zhao J, et al
    Anthracyclines inhibit SARS-CoV-2 infection.
    Virus Res. 2023;334:199164.
    PubMed     Abstract available
    
    
    
100. BERNAL KDE, Whitehurst CB
     Incidence of Epstein-Barr virus reactivation is elevated in COVID-19 patients.
     Virus Res. 2023;334:199157.
     PubMed     Abstract available
     
     
     
101. STRAKOVA P, Bednar P, Kotoucek J, Holoubek J, et al
     Antiviral activity of singlet oxygen-photogenerating perylene compounds against SARS-CoV-2: Interaction with the viral envelope and photodynamic virion inactivation.
     Virus Res. 2023;334:199158.
     PubMed     Abstract available
     
     
     August 2023
102. LEE MM, Cho WK, Cha MH, Yim NH, et al
     The antiviral activity of Thuja orientalis folium against Influenza A virus.
     Virus Res. 2023 Aug 13:199199. doi: 10.1016/j.virusres.2023.199199.
     PubMed     Abstract available
     
     
     
103. TAKAHASHI T, Akagawa M, Kimura R, Sada M, et al
     Molecular evolutionary analyses of the fusion protein gene in human respirovirus 1.
     Virus Res. 2023;333:199142.
     PubMed     Abstract available
     
     
     
104. KO MK, Kim HW, Park SH, Park JH, et al
     The role of zinc sulfate in enhancing cellular and humoral immune responses to foot-and-mouth disease vaccine.
     Virus Res. 2023 Aug 1:199189. doi: 10.1016/j.virusres.2023.199189.
     PubMed     Abstract available
     
     
     July 2023
105. MOEINI S, Mohebbi A, Farahmand B, Mehrbod P, et al
     Phylogenetic analysis and docking study of neuraminidase gene of influenza A/H1N1 viruses circulating in Iran from 2010 to 2019.
     Virus Res. 2023 Jul 23:199182. doi: 10.1016/j.virusres.2023.199182.
     PubMed     Abstract available
     
     
     
106. PRINS MLM, Prins C, de Vries JJC, Visser LG, et al
     Establishing immunogenicity and safety of needle-free intradermal delivery by nanoporous ceramic skin patch of mRNA SARS-CoV-2 vaccine as a revaccination strategy in healthy volunteers.
     Virus Res. 2023 Jul 18:199175. doi: 10.1016/j.virusres.2023.199175.
     PubMed     Abstract available
     
     
     
107. GORI SAVELLINI G, Anichini G, Cusi MG
     SARS-CoV-2 omicron sub-lineages differentially modulate interferon response in human lung epithelial cells.
     Virus Res. 2023;332:199134.
     PubMed     Abstract available
     
     
     
108. LI J, Li X, Mao H, Huang C, et al
     SARS-CoV-2 omicron BA.1.1 is highly resistant to antibody neutralization of convalescent serum from the origin strain.
     Virus Res. 2023;332:199131.
     PubMed     Abstract available
     
     
     June 2023
109. JITOBAOM K, Sirihongthong T, Boonarkart C, Phakaratsakul S, et al
     Human Schlafen 11 inhibits influenza A virus production.
     Virus Res. 2023;334:199162.
     PubMed     Abstract available
     
     
     
110. TAI W, Zheng J, Zhang X, Shi J, et al
     MERS-CoV RBD-mRNA vaccine induces potent and broadly neutralizing antibodies with protection against MERS-CoV infection.
     Virus Res. 2023;334:199156.
     PubMed     Abstract available
     
     
     May 2023
111. ROY A, Sarkar A, Nayak D, Das S, et al
     Ultradiluted SARS-CoV-2 Spike Protein mitigates hyperinflammation in lung via ferritin and MMP-9 regulation in BALB/c mice.
     Virus Res. 2023;329:199091.
     PubMed     Abstract available
     
     
     April 2023
112. NIE Y, Mou L, Long Q, Deng D, et al
     SARS-CoV-2 ORF3a positively regulates NF-kappaB activity by enhancing IKKbeta-NEMO interaction.
     Virus Res. 2023;328:199086.
     PubMed     Abstract available
     
     
     
113. CUI X, Wang Y, Zhai J, Xue M, et al
     Future trajectory of SARS-CoV-2: Constant spillover back and forth between humans and animals.
     Virus Res. 2023;328:199075.
     PubMed     Abstract available
     
     
     
114. CASTILLO G, Mora-Diaz JC, Breuer M, Singh P, et al
     Molecular mechanisms of human coronavirus NL63 infection and replication.
     Virus Res. 2023;327:199078.
     PubMed     Abstract available
     
     
     
115. KLESTOVA Z
     Possible spread of SARS-CoV-2 in domestic and wild animals and body temperature role.
     Virus Res. 2023;327:199066.
     PubMed     Abstract available
     
     
     
116. TALUKDAR SN, Osan J, Ryan K, Grove B, et al
     RSV-induced expanded ciliated cells contribute to bronchial wall thickening.
     Virus Res. 2023;327:199060.
     PubMed     Abstract available
     
     
     
117. ANDRES C, Del Cuerpo M, Rabella N, Pinana M, et al
     Detection of reassortant influenza B strains from 2004 to 2015 seasons in Barcelona (Catalonia, Spain) by whole genome sequencing.
     Virus Res. 2023 Apr 1:199089. doi: 10.1016/j.virusres.2023.199089.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum